Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1

Status

Completed 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 2Sarcoma 1Genitourinary 1

Conditions

Spondylitis, Ankylosing 1Somatoform Disorders 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Breast Neoplasms 1Breast Neoplasm Female 1Bone Neoplasms 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Etoricoxib × Clear all
NCT00095017 2022-02-16

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

Organon and Co

Phase 2 Withdrawn
Sarcoma

Bone Neoplasms

NCT04565600 2022-02-14

Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

Guangdong Provincial People's Hospital

Phase 2 Completed
144 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases, Somatoform Disorders

NCT03117894 2021-06-04

PECS-2 for Breast Surgery

Umeå University

Phase NA Completed
200 enrolled
Breast

Breast Neoplasm Female

NCT00427999 2016-11-21

INV342

Novartis

Phase 2 Completed
67 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT02456363 2015-05-28

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Chung Shan Medical University

Phase 2 Unknown
300 enrolled

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡